Top 5 Most-Read Immuno-Oncology Articles of 2022
December 22nd 2022In 2022, the most-read news about immuno-oncology included an FDA approval for liver cancer, research findings on other potential therapies for liver cancer, a Q&A with a COTA Healthcare executive about how real-world evidence has changed, new possibilities for patients with solid tumors, and more.
Read More
Top 5 Most-Read COVID-19 News of 2022
December 22nd 20222022's most-read news about the pandemic included the impact of COVID-19 on patients with asthma, the Biden administration's plans to advance vaccination and other initiatives, information about when SARS-CoV-2 is at its most infectious, and more.
Read More
The new federal spending bill includes changes to Medicaid enrollment, postpartum coverage, and other health programs; new research shows widened disparities among US adults with diabetes using insulin; in 2022, the Drug Enforcement Administration confiscated more than 379 million fentanyl doses.
Read More
Top 5 Most-Read Articles About Automated Insulin Delivery in 2022
December 20th 2022Content published on AJMC.com focusing on automated insulin delivery devices over the past year highlighted utilization of these devices by age, compared different types of systems, looked at barriers to uptake, and examined equity issues standing in the way of access.
Read More
Among young adults, 2-year cancer survival increased more in states with expanded Medicaid coverage; some pharmacies implemented purchase limits to help combat children’s medicine supply shortages; an FDA advisory panel will meet next month to discuss the state of the COVID-19 pandemic.
Read More
What We’re Reading: Lilly Diabetes Drug Shortage; Medicare Data Breach; New Model for Antibiotics
December 19th 2022Eli Lilly is experiencing a shortage of the diabetes drug tirzepatide (Mounjaro); a data breach has caused over 200,000 Medicare enrollees to receive new identification cards; a restructuring of the current model for developing and selling antibiotics could be a solution to shortages and drug-resistant germs.
Read More
Multiple Barriers Inhibit Optimal Treatment of Endometriosis: Dr Robin Kroll
December 16th 2022Women with endometriosis may experience a delay in optimal care due to a variety of reasons including cultural beliefs, prior authorization hurdles, and more, explained Robin Kroll, MD, medical director, Seattle Clinical Research Center
Read More
COVID-19 vaccines have prevented more than 3.2 million deaths, but the US death rate this year has not declined to prepandemic numbers; Texas Attorney General (AG) Ken Paxton’s office has requested driver’s license records with sex changes from the past 2 years, among other documents, from the Texas Department of Public Safety; even though hepatitis C virus (HCV) is curable, some people who are incarcerated are going without treatment and dying.
Read More
Marcia Horn Discusses Advancements in EGFR Exon 20 Insertion+ NSCLC and the Importance of Community
December 15th 2022There are promising developments in the pipeline for EGFR exon 20 insertion–positive non–small cell lung cancer (NSCLC), and groups like The Exon 20 Group can help ensure patients are getting access to programs to navigate their care.
Read More
Moderna’s mRNA-4157/V940 combined with Merck’s pembrolizumab reduced melanoma recurrence and death; HHS proposed permanently implementing emergency opioid use disorder policies enacted in 2020; maternal death rates were 62% higher in 2020 in states that now have abortion restrictions.
Read More
CMS plans to limit the number of nonstandardized Affordable Care Act (ACA) exchange plans offered by each insurer in 2024; CVS and Walgreens agree to settle on lawsuits revolving around their role in the opioid crisis; cases of COVID-19 rise during the holiday season as people meet with their families.
Read More
ICYMI: Top Highlights From ACC 2022
December 8th 2022The American College of Cardiology’s 71st Scientific Session covered how to address the impact of social determinants of health on cardiovascular outcomes, understanding the latest developments in digital health, and the role of COVID-19 on heart health.
Read More
CMS proposed a rule to streamline the prior authorization process and expand health information access; a scathing report urged the FDA to consider restructuring and potentially dividing the agency; the Institute for Healthcare Improvement (IHI) and American Medical Association (AMA) are coleading the Rise to Health Coalition.
Read More
Pfizer requested authorization for its bivalent COVID-19 vaccine for children aged younger than 5 years; most flu viruses from samples are similar to strains chosen by officials for this year's updated vaccines; Alabama Medicaid agreed to end a longstanding policy allowing refusal to pay for antiviral treatment for hepatitis C in patients with a substance use disorder.
Read More